Equine clonings triple play sheds light on calcium, cell signaling, human disease
The successful cloning of three mules and their excellent health is important to the horse industry, a University of Idaho scientist said Monday at Seattle.
More important is the potential human health aspects of the cloning project. Dr. Gordon Woods, UI professor of animal and veterinary science, said the work aided understanding of calciums role in cell signaling and possibly in the progression of human disease.
Woods, who directs the Northwest Equine Reproduction Laboratory at UI, said increasing calcium levels in the fluid surrounding cloned equine embryos proved the key to equine cloning.
Woods was scheduled to participate in a Feb. 16 panel discussion, Cloning Controversies: Ethics, Science and Society, during the American Association for the Advancement of Science annual meeting.
The birth of the mule foal Idaho Gem on May 4, 2003, marked the first successful equine cloning. The births June 9 of Utah Pioneer and July 27 of Idaho Star, two more mules cloned from the same fetal mule skin cell line, added to the success of the University of Idaho-Utah State University project.
All three mule foals were born unassisted after prototypical pregnancies. All three are vigorous, healthy and developing normally. The triplets were displayed in Seattle during Family Science Day Feb. 15 during the AAAS annual meeting.
"The manipulation of calcium concentrations to achieve success in equine cloning may have implications for other assisted equine reproduction techniques," Woods said. "Increasing intracellular calcium in horses may increase their fertility in general."
Woods began to focus on calcium after becoming interested in why horses appear to be more resistant to some forms of cancer. It is not unusual for light-colored horses to develop melanomas or skin cancers that do not metastasize. Woods found the veterinary literature was devoid of a report of a stallion with prostate cancer. The cancer mortality rate for horses is approximately 8 percent for horses and 24 percent for humans, he said.
Blood samples from men and stallions heightened his interest in calcium. Tests showed intracellular calcium concentrations in horse red blood cells were 2.3 times less than in human red blood cells. Extracellular calcium concentrations were reversed, with 1.5 times greater calcium concentrations outside cells in equines than in humans.
The lower concentrations of calcium within horse cells supported a model proposed by Woods. He postulated the equine system was "slower" physiologically than the human system. The lower cancer rates in equines appeared to support that idea.
Woods connected that hypothesis to embryonic development. "There are electrifying similarities between cancer metastasis and embryo division," said Woods.
Woods collaborators agreed to try stimulating embryonic development by increasing calcium concentrations in the surrounding medium. Dr. Dirk Vanderwall, UI assistant professor of animal and veterinary science, and Dr. Ken White, Utah State University professor of animal, dairy and veterinary science, teamed with Woods on the project.
The results were immediate, Woods said, generating a seven-fold increase in the two-week pregnancy rate of transferred clone embryos. Only two pregnancies lasted two weeks without manipulating calcium levels. Nineteen pregnancies lasted two weeks or more with calcium treatments. Of 21 pregnancies detected at two weeks, 11 lasted 30 days and five lasted 45 days. Three pregnancies lasted past 60 days, and all of them survived full term and resulted in normal births.
The cloning project provided insight into calciums role in cell signaling. As some human diseases progress, calcium levels escalate.
"The connection between calcium and many forms of human disease is well documented," Woods said. Calcium functions as a universal intracellular messenger, controlling processes as diverse as gene transcription, muscle transcription and cell proliferation, Woods noted. A breakdown in calcium regulation is implicated in diseases ranging from cancer to diabetes, heart disease and neurological disorders.
Gordon Woods | EurekAlert!